封面
市場調查報告書
商品編碼
2051041

深層腦部刺激器市場:依產品類型、應用、最終用戶和地區分類

Deep Brain Stimulation Devices Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年深部腦部刺激(DVT)市值為18.4億美元,預計2033年將達到38億美元。預計從2026年到2033年,其複合年成長率將達到10.9%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 18.4億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 10.90% 2033年市場規模預測: 38億美元

近年來,全球深部腦部刺激(DBS)市場經歷了顯著成長。深部腦部刺激(DBS)是一種神經外科手術,透過植入醫療設備,利用植入的電極向大腦特定標靶傳遞電脈衝,從而治療神經和精神疾病。深部腦部刺激有助於緩解帕金森氏症、肌張力不全症和自發性震顫等疾病的症狀。神經醫療設備的科技進步,例如療效更佳、電池壽命更長的可充電設備的研發,正在推動DBS手術的普及。此外,全球老年人口的不斷成長,以及易患神經退化性疾病的人群數量增加,也促進了對深部腦部刺激設備的需求成長。然而,設備成本高昂以及手術複雜,可能會在預測期內在一定程度上抑制市場成長。

市場動態

神經系統疾病盛行率上升、人口老化、對先進治療方法的認知度提高以及技術進步是推動全球深部腦部刺激(DBS)市場成長的關鍵因素。根據帕金森氏症基金會統計,美國每年約有6萬人被診斷出罹患帕金森氏症。同樣,預計未來幾年阿茲海默症及相關失智症的診斷人數也將大幅增加。然而,市場成長可能受到多種因素的限制。深部腦部刺激手術和設備的高昂費用、有限的保險覆蓋範圍以及能夠執行複雜DBS手術的熟練醫務人員短缺,都是該市場面臨的主要挑戰。此外,設備故障問題以及新設備漫長的監管核准流程也阻礙了市場發展。另一方面,持續的研發工作,例如開發具有即時無線編程功能的改進型設備,以及對以患者為中心的護理模式的日益重視,預計將在未來幾年為市場相關人員帶來充滿希望的機會。

本研究的關鍵特徵

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球深部腦部刺激 (DVT) 市場的主要參與者進行了分析:公司亮點、產品系列、主要特點、財務績效和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊可以就未來的產品發布、機器類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球深部腦刺激設備市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球深部腦部刺激 (DPS) 市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球深層腦部刺激器市場:依產品類型分類,2021-2033年

  • 單通道DBS設備
  • 雙通道DBS設備

第5章 全球深層腦部刺激器市場:依應用領域分類,2021-2033年

  • 癲癇
  • 疼痛管理
  • 自發性震顫
  • 強迫症(OCD)
  • 帕金森氏症
  • 憂鬱症
  • 肌張力不全症
  • 其他

第6章 全球深層腦部刺激器市場:依最終用戶分類,2021-2033年

  • 醫院
  • 神經內科診所
  • 門診手術中心
  • 研究中心
  • 其他

第7章 全球深層腦部刺激器市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Neuropace Inc.
  • LivaNova Plc
  • Renishaw Plc
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co. Ltd.
  • Nexstim
  • 聖猶達醫療(現為雅培旗下部門)
  • Cyber​​onics(現為 LivaNova 部門)
  • EBR Systems
  • IntraPace
  • Nevro Corp.
  • Stimwave Technologies

第9章 分析師建議

  • 機會分析
  • 一致的機會地圖

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI84

Deep Brain Stimulation Devices Market is estimated to be valued at USD 1.84 Bn in 2026 and is expected to reach USD 3.80 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.84 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.90% 2033 Value Projection: USD 3.80 Bn

The global deep brain stimulation devices market has been witnessing significant growth over the past few years. Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a brain pacemaker which sends electrical impulses, through implanted electrodes, to specific targets in the brain for treating neurological and psychiatric disorders. Deep brain stimulation helps reduce symptoms of diseases like Parkinson's disease, dystonia, essential tremor among others. Technological advancements in neurological devices like the development of rechargeable devices with improved efficacy and battery life have been fueling the uptake of DBS procedures. Moreover, the growing geriatric population worldwide who are more prone to neurodegenerative disorders has been contributing to the rising demand for deep brain stimulation devices. However, high costs associated with the devices and complexity of procedures might restrain the market growth to some extent during the forecast period.

Market Dynamics

The key factors such as rising prevalence of neurological disorders, increasing geriatric population, growing awareness about advanced treatment options, and technological developments are fueling the growth of the global deep brain stimulation devices market. According to the Parkinson's Foundation, around 60,000 Americans are diagnosed with Parkinson's disease each year. Similarly, the number of people diagnosed with Alzheimer's disease and related dementias is expected to rise dramatically in coming years. However, the market growth can be restrained by some factors. High costs associated with deep brain stimulation procedures and devices, limited reimbursement coverage and lack of skilled healthcare professionals to perform complex DBS surgeries are some of the major challenges faced by the market. Moreover, issues related to device malfunctions and lengthy approval processes for new devices by regulatory authorities also hinder the market progression. On the flip side, ongoing research for development of improved devices with real-time wireless programming and increased focus on patient-centered care present lucrative opportunities for market players in the coming years.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global deep brain stimulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott, Medtronic, Boston Scientific Corporation, Neuropace Inc., LivaNova Plc, Renishaw Plc, Aleva Neurotherapeutics S.A., Beijing Pinchi Medical Equipment Co. Ltd, Nexstim, St. Jude Medical (now part of Abbott), Cyberonics (now part of LivaNova), EBR Systems, IntraPace, Nevro Corp, Stimwave Technologies.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global deep brain stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global deep brain stimulation devices market.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Single-channel DBS Devices
  • Dual-channel DBS Devices
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Epilepsy
  • Pain Management
  • Essential Tremor
  • Obsessive Compulsive Disorder (OCD)
  • Parkinson's Disease
  • Depression
  • Dystonia
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Research Centers
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Neuropace Inc.
  • LivaNova Plc
  • Renishaw Plc
  • Aleva Neurotherapeutics S.A.
  • Beijing Pinchi Medical Equipment Co. Ltd.
  • Nexstim
  • Jude Medical (now part of Abbott)
  • Cyberonics (now part of LivaNova)
  • EBR Systems
  • IntraPace
  • Nevro Corp
  • Stimwave Technologies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Deep Brain Stimulation Devices Market, By Product Type
    • Global Deep Brain Stimulation Devices Market, By Application
    • Global Deep Brain Stimulation Devices Market, By End User
    • Global Deep Brain Stimulation Devices Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Deep Brain Stimulation Devices Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single-channel DBS Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Dual-channel DBS Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Deep Brain Stimulation Devices Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Essential Tremor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Obsessive Compulsive Disorder (OCD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Parkinson's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Dystonia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Deep Brain Stimulation Devices Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Deep Brain Stimulation Devices Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neuropace Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LivaNova Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Renishaw Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aleva Neurotherapeutics S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beijing Pinchi Medical Equipment Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nexstim
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jude Medical (now part of Abbott)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cyberonics (now part of LivaNova)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • EBR Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IntraPace
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nevro Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stimwave Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us